BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19395498)

  • 1. Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out?
    Bartnik M; Cosentino F
    Eur Heart J; 2009 Jun; 30(11):1301-4. PubMed ID: 19395498
    [No Abstract]   [Full Text] [Related]  

  • 2. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Review of the cooperative study of Veterans' affairs on the control and complications of type 2 diabetes, especially cardiovascular diseases].
    Nuttall FQ
    Journ Annu Diabetol Hotel Dieu; 1998; ():99-112. PubMed ID: 9773613
    [No Abstract]   [Full Text] [Related]  

  • 4. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.
    Tushuizen ME; Diamant M; Heine RJ
    Postgrad Med J; 2005 Jan; 81(951):1-6. PubMed ID: 15640422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular complications in diabetes mellitus.
    Sobel BE; Schneider DJ
    Curr Opin Pharmacol; 2005 Apr; 5(2):143-8. PubMed ID: 15780822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-prandial hyperglycaemia and vascular disease.
    Hanefeld M
    Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point.
    Haffner S
    Int J Clin Pract Suppl; 2001 Sep; (123):24-6. PubMed ID: 11594293
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
    Haffner SM
    Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: counterpoint.
    Heine RJ
    Int J Clin Pract Suppl; 2001 Sep; (123):27-9. PubMed ID: 11594294
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetic vascular disease.
    Feingold KR; Siperstein MD
    Adv Intern Med; 1986; 31():309-40. PubMed ID: 3511622
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicity of hyperglycaemia in type 2 diabetes.
    Yki-Järvinen H
    Diabetes Metab Rev; 1998 Sep; 14 Suppl 1():S45-50. PubMed ID: 9816487
    [No Abstract]   [Full Text] [Related]  

  • 13. Early vascular risk factor modification in type 1 diabetes.
    Perkins BA; Bril V
    N Engl J Med; 2005 Jan; 352(4):408-9. PubMed ID: 15673807
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease.
    De Taeye B; Smith LH; Vaughan DE
    Curr Opin Pharmacol; 2005 Apr; 5(2):149-54. PubMed ID: 15780823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-prandial hyperglycemia and microvascular complications.
    Dhanwal D; Tandon N
    J Assoc Physicians India; 2001 Jan; 49 Spec No():28-31. PubMed ID: 11235602
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetes and dyslipidemia].
    Fatati G
    Recenti Prog Med; 1999 Jan; 90(1):21-4. PubMed ID: 10193161
    [No Abstract]   [Full Text] [Related]  

  • 17. [Follow-up of the type 2 diabetic patient excluding follow-up of complications. Recommendations of ANAES].
    Diabetes Metab; 1999 Mar; 25 Suppl 2():1-64. PubMed ID: 10226757
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired glucose tolerance and unidentified diabetes.
    Heine RJ; Mooy JM
    Postgrad Med J; 1996 Feb; 72(844):67-71. PubMed ID: 8871454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of tight blood glucose control in diabetes.
    Andersson DK
    Scand J Prim Health Care; 1995 Jun; 13(2):81-2. PubMed ID: 7569482
    [No Abstract]   [Full Text] [Related]  

  • 20. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes.
    Mazzone T
    J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.